Skip to main content
OpenTrials
Completed

NCT Number: NCT00950131

Testing the Effect of a Warning About New Drugs

The purpose of this study is to test whether a new drug warning decreases enthusiasm for new drugs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants will be randomly selected from a research panel of more than 60,000 U.S. households (Knowledge Networks).

Treatment and study plan

Presentation of information about drug approval and level of warning

Other

Presentation of information about date of drug approval with no new drug warning, a non-directive drug box warning or a directive drug box warning

Primary outcomes

  1. Hypothetical choice of old (vs. newer) drug

    Time frame: 0 weeks (assessed during intervention)

Secondary outcomes

  1. Comprehension of the drug warning and drug information

    Time frame: 0 weeks (assessed during intervention)

Sponsors and collaborators

Lead sponsor

White River Junction Veterans Affairs Medical Center

Fed

Collaborators

  • Attorney General Consumer & Prescriber Education Grant

Registry information

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
Jul 31, 2009
Registry last updated
Apr 9, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.